(Q53313597)

13 May 2018

title

Revising the definition of Alzheimer's disease: a new lexicon. (English)

1 reference

13 May 2018

1 reference

2

1 reference

13 May 2018

Giovanni B. Frisoni

8

1 reference

13 May 2018

Nick C. Fox

9

1 reference

13 May 2018

John T. O'Brien

15

1 reference

13 May 2018

Yaakov Stern

22

1 reference

13 May 2018

Leonardo C de Souza

Leonardo C de Souza

21

0 references

Philip Scheltens

24

Philip Scheltens

1 reference

13 May 2018

12

Harald Hampel

1 reference

13 May 2018

Florence Pasquier

16

0 references

Martin Rossor

Martin Rossor

18

0 references

Steven T. DeKosky

Steven T Dekosky

5

0 references

Pascale Barberger-Gateau

6

Pascale Barberger-Gateau

1 reference

13 May 2018

4

Jeffrey L Cummings

1 reference

13 May 2018

10

Douglas Galasko

1 reference

13 May 2018

Marie Sarazin

20

Marie Sarazin

1 reference

13 May 2018

Claudia Jacova

3

Claudia Jacova

1 reference

13 May 2018

André Delacourte

7

André Delacourte

1 reference

13 May 2018

Kenichi Meguro

14

Kenichi Meguro

1 reference

13 May 2018

Stephen Salloway

19

Steven Salloway

1 reference

13 May 2018

Gregory A Jicha

13

Gregory A Jicha

1 reference

13 May 2018

author name string

Bruno Dubois

1

1 reference

13 May 2018

Serge Gauthier

11

1 reference

13 May 2018

Philippe Robert

17

1 reference

13 May 2018

Pieter J Visser

23

1 reference

13 May 2018

publication date

9 October 2010

1 reference

13 May 2018

published in

Lancet Neurology

1 reference

13 May 2018

volume

9

1 reference

13 May 2018

page(s)

1118-1127

1 reference

13 May 2018

issue

11

1 reference

13 May 2018

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

1 reference

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Neuropathology of cognitively normal elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Prediction of pathology in primary progressive language and speech disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Primary progressive aphasia and the growing role of biomarkers in neurological diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Focal cortical presentations of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Relationships between biomarkers in aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Subregional neuroanatomical change as a biomarker for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Alzheimer disease: operating characteristics of PET--a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Amyloid imaging in mild cognitive impairment subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

The use of PET in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Preliminary evidence of validity of the revised criteria for Alzheimer disease diagnosis: report of 2 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Longitudinal study of the transition from healthy aging to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Disease-modifying therapies for Alzheimer disease: challenges to early intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

'Prodromal Alzheimer's disease': a more useful concept than mild cognitive impairment?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Amnestic MCI or prodromal Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Functional impairment in instrumental activities of daily living: an early clinical sign of dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

In vivo mapping of amyloid toxicity in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

CSF neurofilament proteins in the differential diagnosis of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Imaging amyloid deposition in Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

The neuropathology of older persons with and without dementia from community versus clinic cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970223-4

7 January 2021

10.1016/S1474-4422(10)70223-4

Identifiers

DOI

1 reference

13 May 2018

release_5llokkpj4bfrvbno6o2ltqboxa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5llokkpj4bfrvbno6o2ltqboxa

24 November 2022

mapped directly with Wikidata item

PubMed ID

20934914

1 reference

13 May 2018